FOR PHARMACISTS · SCIENTIFIC COLLECTION 10.0310 monographs · 36 SOPs · 22 forms

CGR-ES-068 / EDITION 10.0

Mentholated zinc oxide powder PO020

Cutaneous powder · Spain · AEMPS

2026-10-14Reference monograph · Local adoption

REFERENCE FORMULA

Reference formula

Reference basis: 90 g

IngredientSource quantityScaled quantity
Racemic menthol8 g—
Zinc oxide10 g—
Talc37 g—
Maize starch35 g—

REFERENCE FORMULA SCALING

Proportional quantities of the same formula

Arithmetic aid. It does not change strength, dose, method or BUD and does not authorise compounding.

Scaling

Prerequisite formulations

No separate prerequisite monograph is listed.

Documentation

Preparation description
White powder with menthol odour. [1]
Action and use
Symptomatic relief of itching/mild irritation; plantar hyperhidrosis according to the source. [1]
Specifications
White powder with menthol odour. [1]
Light
Finished-product photostability is not specified. Any required container light protection is stated under Storage. [1]
Air and oxidation
No oxidative stability study of the finished mixture or inert-atmosphere requirement is provided. Use the source container. [1]
Water and solubility
ZnO: practically insoluble in water and ethanol.
Menthol: practically insoluble in water, readily soluble in fixed oils and liquid paraffin, very slightly soluble in glycerol.
Talc: JP classifies the corresponding pure raw material as practically insoluble in water. [2], [3], [6]
Humidity
For the finished product the source specifies:
Powder sprinkler container; protect from moisture. [1]
Temperature
Racemic menthol melts at approximately 34 °C; this is a raw-material processing characteristic. [3]
pH and compatibility
ZnO dissolves in dilute mineral acids and forms soaps with fatty acids. [2]
Other interactions
Menthol forms eutectic mixtures with camphor/thymol; incompatible with strong oxidants. [3]
Ingredient-specific information
Zinc oxide: light, white to slightly yellowish, amorphous powder without aggregates. Dilute mineral acids dissolve it; fatty acids in a base can form zinc salts.
Talc: raw-material water solubility is classified as practically insoluble by JP. [2], [6]
Staff protection
Menthol: eye protection and prevention of contact/dust inhalation.
Clean long-sleeved laboratory clothing, hair covering and gloves during handling; change gloves after contamination or damage.
Contain powder during weighing and trituration and use eye protection; select respiratory protection for the actual exposure. [3], [4], [7]
Risk assessment
Menthol: prevent contact with nasal mucosa in small children; laryngeal spasm and collapse have been reported below age 2. Avoid open wounds and mucosa.
Reference batch: 90 g. First ingredient: Racemic menthol, 8 g. Independently check chemical form, units and every scale conversion before weighing.
Weighing, sieving and trituration can disperse inhalable powder. Contain at source, check contamination of nearby preparations and avoid blowing or dry sweeping during cleaning.
For the local assessment record quantity per preparation, work frequency, duration of open handling, potential exposure routes and effectiveness of controls. These are assessment inputs; no fictitious final risk score is assigned.
Release checkpoint: independently verify mg per unit, total unit count and smallest weighable quantity. Mass uniformity does not replace content uniformity when required. Document geometric dilution and prevention of powder segregation. [1], [3], [10], [12]
Compounding conditions
Before mixing: verify each ingredient’s chemical form and lot, record theoretical amounts and check equipment cleanliness. Follow the temperatures and addition sequence in the procedure below. [1], [7]
BUD rationale
Period reported by source: 3 months under the source conditions.
This duration is a specific formulary/source instruction. This review did not verify a complete primary study establishing chemical, physical and microbiological extension for the same finished formulation.
Selected general rule: up to 180 days at 20–25 °C for a solid or nonaqueous nonoral-liquid form with supported aw <0.6. Initial quality/moisture, exclusion of water ingress and physical suitability must support this category.
The reference-policy ceiling in this edition is the shorter of the source period above and the general ceiling. Extension needs matching active/excipients/strength, container, temperature, a stability-indicating method and the required microbiological evidence for aqueous extension. An applicable official USP–NF compounded monograph is assessed separately in its complete text.
Use-by date = the earliest allowed date from preparation plus selected period, ingredient expiries and any shorter supported limit. In-use dating never extends overall BUD. Complete the actual date for the batch after the required checks.
A default is a conservative dating limit, not experimental proof of batch stability. Its category depends on final composition, preservation and permitted temperatures. Water percentage or loss on drying does not determine aw. Document using SOP-014/F-006; use SOP-017/F-012 for specific aw evidence.
USP does not require water-activity measurement for every nonsterile preparation. A justified classification of the actual formulation may guide dating; record it explicitly as inferred, not measured. Uncertain or borderline classification requires specific evidence or a suitable measurement. Finished-product dating does not outlast the available dating of previously compounded components/bases unless adequate specific evidence for the exact finished preparation has been formally adopted.
Register correction: at most 89 days as a conservative reference cap before any shorter expiry/component date. This edition converts one calendar month to 28 days and three calendar months to 89 days; weeks are converted to seven days. Original source units are retained. This is an editorial conversion policy, not a new stability result or automatic release. [1], [8], [9], [11], [13]
Prerequisites
No separately registered base is required. Any commercial vehicle remains the exact named product in the formula table. [1]
Equipment
Balance, mortar/pestle, suitable sieve, mixing vessel and powder containment. [1]
Compounding method
Weigh, triturate and mix powders uniformly in the table order. Apply PN/L/OF/002/00. [1], [5]
Observations
The final quantity is the master-formula basis. Record actual yield, losses and deviations in the batch record. [1]
Container and packaging
Powder sprinkler container; protect from moisture. [1]
Quality control
White powder with menthol odour.
Record the method, acceptance criterion, actual result and reviewer separately in F-005. A critical specification failure requires quarantine and investigation under SOP-015; retesting needs justification. [1], [12]
Storage
Powder sprinkler container; protect from moisture. [1]
Dispensing
Not under 2 years. Do not inhale. Avoid eyes, nose, mucosa and open wounds. Not for infected or inflammatory/exudative dermatoses. [1]
Labelling
Mentholated zinc oxide powder PO020
External use
Quantity: ____ Batch: ____
Prepared: ____ Use by: ____
Patient / dose / frequency: ____
Storage: Powder sprinkler container; protect from moisture.
Temperature for this batch BUD: ____ [1]
v9_controls
The numeric value is a literature reference ceiling subject to its specific conditions. No actual batch BUD has been assigned and no aw measurements have been produced. The exact formula, prerequisites, container, storage and quality evidence require approval for the actual application. The BUD clock starts when compounding begins. Use the shortest applicable supported limit and assess in-use dating separately. USP categories are a technical framework and are not presented as Greek legislation.

Independent Greek/English adaptation and organisation of facts from the cited source. This is not an official translation or publisher endorsement.

Sources and references

  1. FN/2003/PO/020 POLVOS DE ÓXIDO DE ZINC MENTOLADOSFN/2003 • ηλεκτρονικό κείμενο με NIPO 2020/2022 / electronic text with NIPO 2020/2022PDF pp. 2–3master formula2026-09-10
  2. FN/2003/PA/028 ÓXIDO DE ZINCΔιαθέσιμο κείμενο / Retrieved textPDF pp. 1–2raw material or occupational2026-09-10
  3. FN/2003/PA/021 MENTOL RACÉMICOΔιαθέσιμο κείμενο / Retrieved textPDF pp. 1–2raw material or occupational2026-09-10
  4. PN/L/PG/002/00 INDUMENTARIAΔιαθέσιμο κείμενο / Retrieved textPDF pp. 1–5general staff protection2026-09-10
  5. PN/L/OF/002/00 MEZCLADO DE POLVOSΔιαθέσιμο κείμενο / Retrieved textPDF pp. 1–6preparation sop2026-09-10
  6. MHLW — Japanese Pharmacopoeia XVIII: TalcJP XVIII, 2021; English textPrinted p. 1772; Description; Containers and storageraw-material monograph2026-09-12
  7. ASHP — USP <795> Key Changes2023pp. 1–3: scope, water activity and staff precautionsprofessional guidance; not the licensed USP chapter2026-09-12
  8. Texas State Board of Pharmacy — adopted 22 TAC §291.131, nonsterile compoundingTexas Register, 7 June 2024Beyond-use dating: aw categories, 14/35/90/180 days, limits and extensionspublic regulatory implementation of USP <795> BUD framework; not Greek law2026-09-12
  9. Illinois IDFPR — Nonsterile Compounding Self-Inspection ReportPublic checklist, retrieved 12 September 2026pp. 15–16, Establishing beyond-use datesPublic regulatory implementation of USP <795>; not Greek law; general limits and requirements for extension2026-09-12
  10. NIOSH — Managing Hazardous Drug Exposures: Information for Healthcare Settings2023; DHHS (NIOSH) 2023-130Risk assessment; printed pp. 27–33, activity/formulation control tableWorkplace exposure, hierarchy of controls and activity-specific PPE; US government public-domain document2026-09-12
  11. USP — Compounding Standards and Beyond-Use Dates, 2022 updateNovember 2022, published by USP; public copy hosted by Mississippi Boardpp. 1–2; nonsterile tableRisk-based default categories; not product-specific stability or Greek law2026-09-12
  12. PIC/S — Guide to Good Practices for the Preparation of Medicinal Products in Healthcare EstablishmentsPE 010-4, 1 March 2014Chapters 1–9; Annex 2 (nonsterile liquids, creams, ointments)Professional quality-system framework; not automatic national legal adoption or certification2026-09-12
  13. USP — General Chapter <795> FAQs (official, updated 1 November 2023)Updated 1 November 2023; retrieved 14 October 2026Q52, Q61–64; use with the applicable full chapterWater-activity classification, component dating and BUD documentation; general professional framework, not a Greek legal adoption or formula-specific study2026-10-14